• Founded: 2015
  • Location: San Diego, CA
  • Employee range: 50 - 200
  • Funding: $75M C Jan 2021; $4M B Jul 2018
  • Investors: Deerfield Management , GV, Alexandria Venture Investments, ARCH Venture Partners, Biomatics Capital, Decheng Capital, Tao Capital Partners, Nan Fung Life Sciences



job board

Short description:

Protein Analysis Technologies

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

Encodia is developing technology to facilitate protein sequencing that can be used for personalized medicine. Difficulties in analyzing the proteome of a cell have limited the potential use case of this information in disease diagnosis and treatment. To overcome this, Encodia has created ProteoCodeTM, their breakthrough reverse-translation technology that enables the analysis of protein sequences. The technology works by using NGS-based amino acid barcoded libraries turning peptide sequence information into a DNA library. ProteoCodeTM can be integrated with other omic approaches, provides in depth information on cellular processes and can be easily scaled to population-level studies.


Linux System Administrator
San Diego, California|16 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com